Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd. on March 7, 2024. Post the acquisition, Guiyang Xintian will hold 100% in Shanghai Huilun Biotechnology.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.77 CNY | -1.67% | -3.29% | -5.54% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.54% | 375M | |
+15.09% | 78.37B | |
+11.65% | 9.08B | |
+54.35% | 4.85B | |
-12.85% | 5.06B | |
+1.60% | 3.85B | |
-20.85% | 2.36B | |
+16.88% | 2.37B | |
-29.25% | 2.22B | |
+24.62% | 2.27B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd.